As avid travelers, my husband and I couldn’t wait to show our son the world, so we applied for his first passport when he was just 1 month old. But between our work schedules and other logistics, it ...
The FDA has accepted Pharming Group’s supplemental new drug application for leniolisib in treating activated phosphoinositide ...
Pfizer's vaccine for kids under 5 is 80% effective against symptomatic COVID. Pfizer announced Wednesday that it has completed its application to the U.S. Food and Drug Administration for a three-dose ...
Johnson & Johnson (JNJ) has submitted a new application to the U.S. FDA to expand the use of Stelara (ustekinumab) for treating children aged two and older with moderate to severe ulcerative colitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback